Cargando…
Humoral Immune Response of SARS-CoV-2 Infection and Anti-SARS-CoV-2 Vaccination in Renal Transplant Recipients
Vaccination-induced SARS-CoV-2 neutralizing antibodies are required for herd immunity. Vaccine availability and poor vaccine response in renal transplant recipients (RTRs) remain a concern. There is no report on the efficacy of Covaxin and Covishield vaccines in RTRs. We recruited 222 live donors RT...
Autores principales: | Prasad, Narayan, Yadav, Brijesh, Singh, Mantabya, Gautam, Sonam, Bhadauria, Dharmendra, Patel, Manas, Kushwaha, Ravi, Yadav, Deependra, Singh, Ankita, Yachha, Monika, Behera, Manas, Kaul, Anupama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950490/ https://www.ncbi.nlm.nih.gov/pubmed/35335017 http://dx.doi.org/10.3390/vaccines10030385 |
Ejemplares similares
-
Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center
por: Prasad, Narayan, et al.
Publicado: (2022) -
Association of Human Leucocyte Antigen Polymorphism with Coronavirus Disease 19 in Renal Transplant Recipients
por: Prasad, Narayan, et al.
Publicado: (2022) -
Antibody Response to ChAdOx1 nCoV-19 (AZD1222) Vaccine in Kidney Transplant Recipients
por: Bhadauria, Dharmendra S., et al.
Publicado: (2022) -
Two Decades Outcomes of Posttransplant Immunoglobulin A Nephropathy in Live Donor Renal Transplantation
por: Khurana, Mudit, et al.
Publicado: (2022) -
SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2021)